The hemodynamic monitoring company.
10-Oct-2017
Interim Results For The 6 Months To End July 2017 – Seems disappointing.
Nothing to excite me here really – Revenues up 4% to £3.9m (H1 2016: £3.8m), Gross Profit up by 7% to £2.7m (H1 2016: £2.5m), EBITDA Loss for the period -£0.6m (H1 2016: £0m).
Subsequent note: Fallen way below my £30m Market Cap cut off point now (£10.6m at the time of writing) and still loss making – Moved to my Avoid list for now.
Advertisement
